EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia

Shunjie Yu, Sen Yang, Lijuan Hu, Wenbing Duan, Ting Zhao, Yazhen Qin, Yazhe Wang, Yueyun Lai, Hongxia Shi, Feifei Tang, Yuqian Sun, Jinsong Jia und 9 weitere

Annals of Hematology · 2025-02 · 104 (2) · 997-1006

DOI: 10.1007/s00277-024-06182-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 10.01.2025. Verfasst von Shunjie Yu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, Na…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Core Binding Factor Alpha 2 Subunit, Mutation, Core Binding Factors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteCore Binding Factor Alpha 2 SubunitMutationCore Binding FactorsHumansMaleFemaleMiddle AgedAdultAgedAdolescentHistone DemethylasesYoung AdultRUNX1 Translocation Partner 1 ProteinPrognosisAged, 80 and overCore Binding Factor beta SubunitDisease-Free SurvivalOncogene Proteins, Fusionfms-Like Tyrosine Kinase 3Myosin Heavy Chains

Stichwörter der Autor:innen

Acute myeloid leukemiaCore binding factorGenomicSurvival prognosis

Substanzen

Core Binding Factor Alpha 2 SubunitRUNX1 protein, humanKDM6A protein, humanHistone DemethylasesRUNX1 Translocation Partner 1 ProteinRUNX1T1 protein, humanCore Binding Factor beta SubunitOncogene Proteins, Fusionfms-Like Tyrosine Kinase 3MYH11 protein, human

Autor:innen und Institutionen

  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Peking Univer…
  • Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
  • Peking University People's Hospital, Qingdao, China. jiangqian@medmail.com.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, S., Yang, S., Hu, L., Duan, W., Zhao, T., Qin, Y., Wang, Y., Lai, Y., Shi, H., Tang, F., Sun, Y., Jia, J., Wang, J., Lu, S., Fu, Q., Jiang, H., Xu, L., Wang, Y., Zhang, X., …, & Jiang, Q. (2025). Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia. Annals of Hematology, 104(2), 997-1006. https://doi.org/10.1007/s00277-024-06182-0

Vancouver

Yu S, Yang S, Hu L, Duan W, Zhao T, Qin Y, et al. Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia. Annals of Hematology. 2025;104(2):997-1006. doi:10.1007/s00277-024-06182-0

BibTeX
@article{Yu2025,
  author = {Yu, Shunjie and Yang, Sen and Hu, Lijuan and Duan, Wenbing and Zhao, Ting and Qin, Yazhen and Wang, Yazhe and Lai, Yueyun and Shi, Hongxia and Tang, Feifei and Sun, Yuqian and Jia, Jinsong and Wang, Jing and Lu, Shengye and Fu, Qiang and Jiang, Hao and Xu, Lanping and Wang, Yu and Zhang, Xiaohui and Huang, Xiaojun and Jiang, Qian},
  title = {Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {2},
  pages = {997--1006},
  doi = {10.1007/s00277-024-06182-0}
}
Kostenlos starten →